Nova director Cohen proposes $1.04M share sale

The notice gives November 10, 2026, as the approximate sale date under a Rule 10b5-1 trading plan.

Available on EDGAR 11/10/2026 - 08:27 AM EST Accepted by SEC EDGAR 11/10/2026 - 08:26 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

NOVA LTD. director Rani (Raanan) Cohen reported a proposed sale of 3,121 ordinary shares. The listed aggregate market value is $1,040,042.04, and the approximate sale date is November 10, 2026. The sale is pursuant to a Rule 10b5-1 trading plan adopted on August 11, 2026. Yohanan Azriel signed as an authorized signatory of Oppenheimer Israel under delegation.

Key Figures

Ordinary shares proposed for sale: 3,121 shares Aggregate market value: $1,040,042.04 Approximate sale date: November 10, 2026 +1 more

4 metrics

Ordinary shares proposed for sale 3,121 shares Proposed sale by Rani (Raanan) Cohen

Aggregate market value $1,040,042.04 Securities listed for sale

Approximate sale date November 10, 2026 Proposed sale

Ordinary shares outstanding 31,780,111 shares Number listed as outstanding

Key Terms

Rule 10b5-1 trading plan, Cashless (net) exercise of stock options, RSUs

3 terms

Rule 10b5-1 trading plan regulatory

"sold pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Cashless (net) exercise of stock options financial

"Cashless (net) exercise of stock options"

RSUs financial

"shares issued upon vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NVMI shares is Rani (Raanan) Cohen proposing to sell?

Rani (Raanan) Cohen reported a proposed sale of 3,121 ordinary shares, with an aggregate market value of $1,040,042.04. The approximate sale date is November 10, 2026, pursuant to a Rule 10b5-1 trading plan adopted on August 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001960005
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NOVA LTD.
SEC File Number	000-30668
Address of Issuer	5 David Fikes St. Rehovot ISRAEL 7632805
Phone	972-73-229-5600
Name of Person for Whose Account the Securities are To Be Sold	Rani (Raanan) Cohen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	3121	1040042.04	31780111	11/10/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	05/03/2024	Shares acquired upon exercise of employee stock options	NOVA LTD.			3	05/03/2024	Cash payment upon exercise of stock options
Ordinary Shares	11/10/2026	Shares acquired upon exercise of employee stock options	NOVA LTD.			665	11/10/2026	Cashless (net) exercise of stock options
Ordinary Shares	06/24/2022	Shares issued upon vesting of RSUs	NOVA LTD.			639	06/24/2022	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	06/23/2023	Shares issued upon vesting of RSUs	NOVA LTD.			1814	06/23/2023	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b5-1 trading plan adopted on 08/11/2026
Date of Notice	11/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rani (Raanan) Cohen By: /s/ Yohanan Azriel Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)